Skip to content

Tribute Pharmaceuticals Canada Inc.

CIK 0001159019

← back to feed
Revenue (TTM)
$24.9M
+25.5% YoY Q3 Sep 2015
Net Income (TTM)
−$9.39M
+14.7% YoY Q3 Sep 2015
EPS Diluted (TTM)
−$0.06
+38.5% YoY Q3 Sep 2015
Gross Margin
61.1%
Q3 Sep 2015
Operating Margin
7.6%
Q3 Sep 2015
Net Margin
-37.7%
Q3 Sep 2015
Free Cash Flow (TTM)
−$9.57M
Q3 Sep 2015
Cash
$13.23M
Q3 Sep 2015
Total Debt
$30.26M
Q3 Sep 2015
Shares Outstanding
126.24M sh
Q3 Sep 2015

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings